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New York, NY
Background: The benefit of carotid endarterectomy (CEA) in female patients has been questioned by various randomized,
prospective trials, particularly in asymptomatic cases; several have noted an increase in perioperative stroke among women
after CEA. The outcome of carotid angioplasty and stenting (CAS) has not been extensively examined in women. This
study examined the outcome of CEA and CAS in women vs men by using a national database.
Methods: Outcomes of CEA and CAS were stratified by sex using discharge data from the Nationwide Inpatient Sample
(NIS), Healthcare Cost andUtilization Project (HCUP), Agency forHealthcare Research andQuality. TheNIS was used
to identify patient discharges that occurred during 2004 and 2005. Appropriate International Classification of Diseases,
9th Revision (ICD-9) procedure and diagnosis codes were used to identify CEA and CAS cases. Outcome measures
included in-hospital perioperative stroke and death. Comparisons of demographics, procedures, and outcome were
performed between men and women. Additional analysis was performed among women alone to attempt to identify
whether improved outcome was noted with either procedure.
Results: Of 54,658 procedures, 94.2% were CEA and 5.8% were CAS. Women comprised 42.3% of the analyzed cases.
Women and men were equally likely to be symptomatic (5.3% vs 5.3%, P  .8). Women were significantly less likely to
undergo CAS than men (5.4% vs 6.1%, P < .001). Women and men had equivalent rates of perioperative stroke when
undergoing CEA (1.0% vs 1.0%, P .9) and CAS (2.7% vs 2.0%, P .2). Symptomatic women had a significantly higher
rate of perioperative stroke overall than did symptomatic men (3.8% vs 2.3%, P  .03). Asymptomatic women had a
significantly lower perioperative stroke rate after CEA than after CAS (0.9% vs 2.1%, P < .001). Rates of perioperative
showed a trend favoring CEA vs CAS among symptomatic women (3.4% vs 6.2%, P  .1).
Conclusions: The concern regarding an increased perioperative stroke rate after CEA among asymptomatic women appears to
be unfounded. The perioperative stroke rate among symptomatic women was higher than that of symptomatic men, but still
well within the acceptable range for symptomatic patients undergoing a cerebrovascular intervention. Nationally, women
underwentCAS significantly less frequently than didmen.Outcome amongwomen for perioperative stroke favoredCEAover
CAS, particularly in asymptomatic patients. CEA may be the preferred treatment in women seeking intervention for
cerebrovascular disease, unless compelling reasons exist to perform CAS. (J Vasc Surg 2011;53:1457-65.)
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gAlthough the results of the Asymptomatic Carotid
Atherosclerosis Study (ACAS)1 demonstrated the benefit
of carotid endarterectomy (CEA) over concurrent best
medical therapy for severe carotid artery disease, the true
benefit for female patients was questionable. CEA reduced
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doi:10.1016/j.jvs.2011.02.029he 5-year event rate by 17% in women compared with a
6% reduction in men.1,2 ACAS suggested that this dispar-
ty was largely accounted for by a higher rate of periopera-
ive stroke and complications in the 281 female patients in
he trial who underwent CEA; the perioperative complica-
ion rate was 3.6% for female patients vs 1.7% for male
atients. Based largely on data from ACAS and other
ubsequent studies, interpretations of the extensive litera-
ure on this topic have diverged widely. Many clinicians
emain concerned that female patients might not derive a
ignificant benefit from prophylactic CEA or carotid angio-
lasty and stenting (CAS).
Many subsequent studies have attempted to elucidate
he role that sex plays in affecting outcomes after carotid
rtery interventions, including CEA and carotid artery an-
ioplasty and stenting (CAS). Studies have reported a wide
ange of outcomes, ranging from no significant differences
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June 20111458 Rockman et albased on sex, to significantly higher perioperative neuro-
logic complication rates in female patients compared with
their male counterparts. Fewer data are available on the
outcome of CAS with specific attention towards sex. The
authors’ institutional experience reported previously has
shown that sex has no effect on the perioperative compli-
cation rate.2 The objective of this study was to examine the
national outcome of both CEA and CAS in female patients
compared with male patients by using a national database.
METHODS
The Nationwide Inpatient Sample (NIS), Healthcare
Cost and Utilization Project (HCUP), Agency for Health-
care Research and Quality, was used to identify patient
discharges that occurred during 2004 and 2005. TheNIS is
a 20% sampling of abstracted discharge data from a national
survey of all nonfederal acute-care hospitals in the United
States.3 For the purposes of this study, the patients were
drawn directly from the 20% sample; the weighting strategy
to allow estimates to be made at the national level was not
used. Appropriate International Classification of Diseases,
9th Revision (ICD-9) procedure and diagnosis codes were
used to identify patients undergoing CEA and CAS.
Outcome measures included in-hospital perioperative
stroke and death. Comparisons of demographics, proce-
dures, and outcome were performed between men and
women. Additional analysis was performed among female
patients alone to attempt to identify whether improved
outcome was noted with either procedure. The analysis
excluded patients identified as undergoing coronary artery
bypass grafting during the same admission.
Once appropriate patients were identified using CEA
and CAS ICD-9 codes, missing data analysis was per-
formed. The designation of sex was missing for 48 patients,
and these were excluded from analysis. Of the 54,658
patients, the preoperative symptomatic status could not be
ascertained from the diagnosis coding in 737 (1.3%); these
patients were excluded from the specific analyses involving
comparisons of the preoperative symptoms. All other ana-
lyzed variables were complete.
Standard statistical analysis was performed using SPSS
software (SPSS Inc, Chicago, Ill). Fisher exact test or 2
Table I. Comparison of preoperative symptoms, procedur
female patients undergoing all carotid artery revascularizati
Variableb
Male
(n  31,496)
Asymptomatic 94.7 (29,409)
Symptomatic 5.3 (1645)
CAS 6.1 (1937)
CEA 93.9 (29,559)
Postoperative stroke 1.1 (346)
In-hospital death 0.7 (227)
CAS, Carotid angioplasty and stenting; CEA, carotid endarterectomy.
aCombined carotid endarterectomy and carotid angioplasty and stenting.
bData are presented as percentage (n).analysis was used where appropriate to compare categoric aariables. A result was considered to be statistically signifi-
ant with a value of P  0.05.
ESULTS
The analysis of 54,658 cases showed 51,427 (94.2%)
ere CEA, and 3183 (5.8%) were CAS. Overall, women
omprised 23,114 (42.3%) of the analyzed cases.
Comparison of male and female patients. Overall,
ale and female patients who underwent carotid revascu-
arization procedures were equally likely to have had pre-
perative neurologic symptoms (5.3% vs 5.3%, P  .8).
ale patients were significantly more likely to undergo
AS than were female patients (6.1% vs 5.4%, P  .0001).
ale and female patients had essentially identical rates of
ostoperative stroke (1.1% vs 1.1%, P .7). However, male
atients were more likely to die in the hospital (0.7% vs
.6%, P  .03; Table I).
Comparisons were performed between male and fe-
ale patients stratified by the presence of preoperative
ymptoms (Table II). When asymptomatic patients alone
ere examined, again male patients were significantly more
ikely to undergo CAS than were female patients (5.8% vs
.8%, P  .001). There were no significant differences
oted between asymptomatic male and female patients for
ostoperative stroke (1.0% vs 0.9%, P  .7) or in-hospital
ortality (0.4% vs 0.4%, P  .4).
When symptomatic patients alone were examined, male
nd female patients were equally likely to undergo CAS vs
EA (11.9% vs 13.5%, P  .2). However, symptomatic
omen had a significantly higher rate of postoperative
troke overall than symptomatic men (3.8% vs 2.3%, P 
03). No significant difference was noted in the rate of
n-hospital mortality rates between symptomatic male and
emale patients (3.3% vs 2.3%, P  .14; Table II).
Comparison of male and female patients stratified
y CEA. Male and female patients who underwent CEA
Table III) were equally likely to be symptomatic (5.0% vs
.8%, P .4) and had an equal rate of postoperative stroke
1.0% vs 1.0%, P .9).Men undergoing CEA had a slightly
igher rate of in-hospital mortality than women undergo-
ng CEA (0.7% vs 0.5%, P  .02).
When asymptomatic patients alone were analyzed,
formed, and postoperative outcome between male and
roceduresa
emale Overall
P23,114) (n  54,658)
(21,621) 94.7 (51.030) .8
(1199) 5.3 (2833) .8
(1246) 5.8 (3183) .0001
(21,868) 94.2 (51,427) .0001
(263) 1.1 (609) .7
(131) 0.7 (358) .03e per
on p
F
(n 
94.7
5.3
5.4
94.6
1.1
0.6symptomatic male and female patients who underwent
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Volume 53, Number 6 Rockman et al 1459CEA had no differences in rates of postoperative stroke
(0.9% vs 0.9%, P  .6) or in-hospital mortality (0.4% vs
0.4%, P  .3). Among symptomatic patients who under-
went CEA, however, women had a higher rate of postop-
erative stroke thanmen (3.4% vs 2.1%); this comparison did
not quite reach statistical significance (P .06). No differ-
ence was noted in the in-hospital mortality rate between
symptomatic male and female patients who underwent
CEA (2.7% vs 2.1%, P  .4).
Comparison of male and female patients stratified
by CAS. Among patients who underwent CAS, women
were significantly more likely to be symptomatic than men
(13.5% vs 10.4%, P  .01; Table IV). Despite this, no
overall significant differences were noted in the rates of
postoperative stroke (2.0% vs 2.7%, P .2) and in-hospital
mortality (1.2% vs 1.3%, P  .9) between male and female
patients who underwent CAS.
When patients were analyzed by preoperative symptoms,
no differences were noted in the incidence of postoperative
stroke (1.8% vs 2.1%, P .6) or in-hospital mortality (0.4% vs
0.7%, P .5) between asymptomatic male and asymptomatic
female patients who underwent CAS. Likewise among symp-
tomatic patients, no significant differences were noted in the
Table II. Comparison of procedure performed and postop
undergoing carotid artery revascularization procedures stra
Variableb Male
Asymptomatic, No. 29,409
CAS 5.8 (1696)
CEA 94.2 (27,713)
Post-op stroke 1.0 (291)
In-hospital death 0.4 (130)
Symptomatic, No. 1645
CAS 11.9 (196)
CEA 88.1 (1449)
Post-op stroke 2.3 (38)
In-hospital death 3.3 (55)
CAS, Carotid angioplasty and stenting; CEA, carotid endarterectomy.
aCombined carotid endarterectomy and carotid angioplasty and stenting.
bData are presented as percentage (n).
Table III. Comparison of overall postoperative outcome b
endarterectomy (CEA) and as stratified by the presence of
Variablea Male
All CEA, No. 29,559
Asymptomatic 95.0 (27,713)
Symptomatic 5.0 (1449)
Post-op stroke 1.0 (307)
In-hospital mortality 0.7 (203)
Asymptomatic, No. 27,713
Post-op stroke 0.9 (261)
In-hospital mortality 0.4 (123)
Symptomatic, No. 1449
Postoperative stroke 2.1 (30)
In-hospital mortality 2.7 (39)
aData are presented as percentage (n).rates of postoperative stroke (4.1% vs 6.2%, P  .5) or in- iospital mortality (8.2% vs 3.7%, P  .1) between men and
omen who underwent CAS. Nevertheless, the 8.2% in-
ospital mortality rate for symptomatic male patients who
nderwent CAS was concerning.
Analysis of outcome in female patients stratified by
reoperative symptoms and the procedure. Asymptomatic
omen were significantly more likely to undergo CEA vs CAS
han were symptomatic women (95.2% vs 86.4%, P  .001,
ableV).Of 1037 symptomatic female patientswhounderwent
arotid revascularization, 13.5% underwent CAS. Symptomatic
omen overall had significantly higher rates of postoperative
troke(3.8%vs0.9%,P .001)and in-hospitalmortality (2.3%vs
.4%, P .001) than asymptomatic women.
When stratified by procedure, asymptomatic women un-
ergoing CEA had a significantly lower incidence of postop-
rative stroke than asymptomatic women who underwent
AS (0.9% vs 2.1%, P  .001). Symptomatic women who
nderwentCEAhad a lower incidence of postoperative stroke
han symptomatic women who underwent CAS (3.4% vs
.2%), although this did not quite reach statistical significance
P  .1). No significant differences were noted in the inci-
ence of in-hospital mortality by type of procedure performed
ive outcome between male and female patients
by the presence of preoperative symptomsa
Female Overall P
21,621 51,030
(1037) 5.4 (2733) .001
(20,584) 94.6 (48,297) .001
(205) 1.0 (496) .7
(84) 0.4 (214) .4
1199 2844
(162) 12.6 (358) .2
(1037) 87.4 (2486) .2
(45) 2.9 (83) .03
(28) 2.9 (83) .14
een male and female patients undergoing carotid
perative symptoms
Female Overall P
21,868 51,427
5.2 (20,584) 95.1 (48,297) .4
4.8 (1037) 4.9 (2486) .4
1.0 (229) 1.0 (536) .9
0.5 (115) 0.6 (318) .02
20,584 48,297
0.9 (183) 0.9 (444) .6
0.4 (77) 0.4 (200) .3
1037 2486
3.4 (35) 2.6 (65) .06
2.1 (22) 2.5 (61) .4erat
tified
4.8
95.2
0.9
0.4
13.5
86.5
3.8
2.3etw
preo
9n symptomatic or asymptomatic female patients. However,
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June 20111460 Rockman et althe in-hospital 3.7% mortality rate for symptomatic female
patients undergoing CAS was concerning.
DISCUSSION
Individuals in the field of medicine and the lay public
perceive that atherosclerosis is a considerably more significant
problem among men. These generalizations may have a con-
siderable affect on theway patients are treated and referred. In
particular, stroke is thought to be more common in men.
However, population-based data reveal that the incidence of
ischemic stroke is greater in men than women only until age
65 years, when the incidence of stroke equalizes between the
sexes.4 Because of their overrepresentation in this older age
cohort, women have an equal number of strokes as men on
the whole; in addition, these strokes are occurring at an age
when the outlook for meaningful recovery may be less favor-
able.5 Consequently, stroke prevention is clearly equally im-
portant in women as in men. Sex-related differences in the
Table IV. Comparison of overall postoperative outcome b
angioplasty and stenting (CAS) and as stratified by the pre
Variablea Male
All CAS, No. 1937
Asymptomatic 89.6 (1696)
Symptomatic 10.4 (196)
Post-op stroke 2.0 (39)
In-hospital mortality 1.2 (24)
Asymptomatic, No. 1696
Post-op stroke 1.8 (30)
In-hospital mortality 0.4 (7)
Symptomatic, No. 196
Post-op stroke 4.1 (8)
In-hospital mortality 8.2 (16)
aData are presented as percentage (n).
Table V. Comparison of postoperative outcome in female
stratified by the type of procedure performed, and the pres
Variablea Symptomatic
Female patients 1199
CEA 86.5 (1037)
CAS 13.5 (162)
Postoperative stroke 3.8 (45)
In-hospital death 2.3 (28)
CEA
All females, No. 21,621
Post-op stroke 1.0 (218)
In-hospital death 0.5 (99)
Asymptomatic, No. 20,584
Post-op stroke 0.9 (183)
In-hospital death 0.4 (77)
Symptomatic, No. 1037
Post-op stroke 3.4 (35)
In-hospital death 2.1 (22)
CAS, Carotid angioplasty and stenting; CEA, carotid endarterectomy.
aData are presented as percentage (n).outcome of aortic and peripheral arterial disease are well pocumented,6,7 but outcomes in female patients undergoing
arotid artery interventions for severe extracranial cerebrovas-
ular disease are less well defined.
Female patients with extracranial cerebrovascular dis-
ase may be different in multiple ways from affected male
atients. At the microscopic level, analysis of carotid
laques has demonstrated that those from women con-
ained more smooth muscle cells, had decreased protease
ctivity, and were less likely to disrupt.8 Other factors such
s vessel diameter, estrogen, and sensitivity to antiplatelet
herapy have been investigated, showing discrepancies in
pecimens from men and women.9
Furthermore, the comorbidity profile in women and
en is usually different. In our prior institutional report,
emale patients undergoing CEA were noted to have a
ignificantly lower prevalence of diabetes mellitus, known
oronary artery disease, and contralateral carotid artery
cclusion than male patients, and a significantly higher
en male and female patients undergoing carotid artery
of preoperative symptoms
Female Overall P
1246 3183
6.5 (1037) 88.4 (2733) .01
3.5 (162) 11.6 (358) .01
2.7 (34) 2.3 (73) .2
1.3 (16) 1.3 (40) .9
1037 2733
2.1 (22) 1.9 (52) .6
0.7 (7) 0.5 (14) .5
162 358
6.2 (10) 5.0 (18) .5
3.7 (6) 6.1 (22) .1
ents undergoing carotid revascularization procedures as
of preoperative symptoms
mptomatic Overall P
21,621 22,820
2 (20,584) 94.7 (21,621) .001
8 (1037) 5.3 (1199) .001
9 (205) 1.1 (250) .001
4 (84) 0.5 (112) .001
CAS Overall
1199 22,820
2.7 (32) 1.1 (250) .001
1.1 (13) 0.5 (112) .005
1037 21,621
2.1 (22) 0.9 (205) .001
0.7 (7) 0.4 (84) .2
162 1199
6.2 (10) 3.8 (45) .1
3.7 (6) 2.3 (28) .3etwe
sence
8
1pati
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Asy
95.
4.
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Volume 53, Number 6 Rockman et al 1461The results from ACAS served as an impetus to inves-
tigate the role sex plays on the risk of perioperative compli-
cations from carotid artery interventions, specifically CEA.
Representative reports of the studies that have been pub-
lished on this topic are summarized in Table VI.2,9-29
Almost all of these studies demonstrated an acceptable
perioperative complication rate for female patients, with no
significant differences from male patients. Several studies
however, did show an increased event rate in wom-
en.18,19,21-23 A meta-analysis of the existing literature per-
formed in 2005 by Bond et al30 found that women under-
going CEA did have a higher rate of operative stroke and
death than men (odds ratio, 1.31; 95% confidence interval,
1.17-1.47, P .001). The clinical implication of this small
absolute difference is unclear.
Sarac et al18 reported a 3.3% perioperative event rate in
Table VI. Representative literature comparing outcome o
stenting (CAS) by gender
Study
(first author) Year
Females
(No.)
Males
(No.) Fem
CEA
Schneider10 1997 155 271 3.
Rigdon11 1998 175 254 6.
Rockman12 2000 991 1485 2.
Ballotta13 2000 196 423 2.
Sternbach14 2000 66 83 0
Akbari15 2000 520 778 1.
James16 2001 125 199 2.
Mattos17 2001 464 739 3.
Sarac18 2002 1148 2274 3.
Lane9 2003 115 246 3.
Kapral19 2003 2096 3942 5.
Lee20 2003 600 903 2.
Weise21 2004 56 156 16.
Harthun22 2005 5950 8144 1.
Dorigo23 2009 1200 2809 1.
Halm24 2009 4125 5181 3.
Yavas25 2010 41 150 2.
CAS
Roubin26 2001 489 172 5.
Park27 2008 42 47 2
Goldstein28 2009 97 141 2.
Howard29 2009 579 985 1.
ICA, Internal carotid artery; HRT, hormone replacement therapy.women compared with 2.1% in their male counterparts. In Tarticular, asymptomatic women were at greater risk for a
erioperative event than asymptomatic men. Harthun et
l22 also noted a slight increase in perioperative strokes in
omen than in men; however, in their logistic regression
nalysis, female sex was not independently associated with a
igher stroke or mortality rate. Importantly, when histori-
al rates of stroke in medically managed female patients
ere used for comparison, in neither of these two studies
ere the procedural stroke rates with CEA considered to be
igh enough to warrant solely medical management of the
emale cohort.
Several theories have been proposed to explain why
utcome after CEA might be worse in female patients.
ost reports mention the comparatively smaller size of the
nternal carotid artery in women, which might predispose
owards technical errors or early postoperative thrombosis.
tid endarterectomy (CEA) and carotid angioplasty and
t rate %
P CommentsMales
1.5 .30 No difference based on gender
3.5 NS Highest stroke rate in black females
2.3 .92 No difference in symptomatic or
asymptomatic cohorts
2.2 NS No difference based on gender
1.3 NS No difference in asymptomatic
females
2.1 NS No difference based on gender
2.5 .76 No difference based on gender
5.7 NS Lower stroke rates in symptomatic
and asymptomatic women vs
men
2.1 .03 Increased rate in asymptomatic
women only
1.2 .19 Increased rate with estrogen based
HRT
4.2 NS Increased stroke rate at 2-yr follow-
up for women
2.2 NS No difference based on sex or
preoperative symptoms
9.0 .21 Increased stroke rate in women
with contralateral ICA stenosis/
occlusion
0.87 .04 Increased stroke rate in women;
however, sex not independently
associated with a higher rate of
perioperative neurologic events
1.4 NS Female patients with diabetes or
contralateral occlusion had an
increased risk of an ipsilateral
neurologic event
3.07 .21 No difference based on sex
4.9 .05 No difference based on sex
8.0 0.4 No difference based on sex
0 0.67 No difference based on sex
4.2 0.48 No difference based on sex
3.8 NS No difference based on sex or
symptomsf caro
Even
ales
2
9
4
1
6
4
5
3
6
0
2
1
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2
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3he use of routine patch angioplasty in conjunction with
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June 20111462 Rockman et alCEA at our institution and others might possibly have
helped to overcome any negative effects of the smaller-
sized carotid artery in women.2,12
Fewer studies have been reported specifically investi-
gating the role of sex on the outcome of CAS.26-29 The few
small studies available showed no differences in stroke rate
when men were compared with women.26-28 A systematic
review of the literature regarding the perioperative risk of
stroke or death after CAS found that sex did not predict
poor outcome.31 However, recent data from the Carotid
Revascularization Endarterectomy versus Stenting Trial
(CREST) presented at the 2010 Annual Meeting of the
American Neurological Association reported that the peri-
operative stroke was significantly higher among female
patients who underwent CAS vs CEA.32
In the current analysis, we found no difference in
overall perioperative stroke rates for all carotid interven-
tions when men were compared with women. The rate of
perioperative stroke for male and female patients undergo-
ing all carotid interventions was essentially identical. Male
patients, in fact, had a slightly higher rate of in-hospital
death than female patients (0.7% vs 0.3%). When stratified
by the presence of preoperative symptoms, asymptomatic
male and female patients undergoing carotid intervention
had a nearly identical rate of postoperative stroke and
in-hospital death. However, symptomatic women under-
going carotid artery interventions had a significantly higher
rate of postoperative stroke than symptomatic men (3.8% vs
2.3%, P  .03). The clinical significance of this finding is
unclear. It is possible, of course, that symptomatic female
patients would be at a higher risk for future stroke if no
intervention were performed and still benefit from inter-
vention vs medical management. Nevertheless, a postoper-
ative stroke rate of 3.8% for symptomatic female patients is
well within the standard of care. Furthermore, in the overall
comparison of male and female patients, this is the only
category of patients in which a difference in the postoper-
ative event rate was found.
When stratifying by the procedure performed (CEA vs
CAS), again, the results of male and female patients were
remarkably similar. When looking at CEA alone, men un-
dergoing CEA had a significantly higher rate of in-hospital
mortality than women (0.7% vs 0.5%, P  .02). The only
difference in the rates of postoperative stroke with CEA
were in symptomatic female patients compared with symp-
tomatic male patients (3.4% vs 2.1%), but this difference did
not reach statistical significance. A comparison of male and
female patients undergoing CAS found no significant dif-
ferences between the outcome of male and female patients
overall, or when stratified by the presence of preoperative
symptoms. Our findings suggest that women do not have
an increased rate of perioperative complications after inter-
vention for carotid occlusive disease and that the indica-
tions for carotid intervention should not be influenced by
sex. In particular, the concern regarding an increased rate of
complications for asymptomatic female patients appears to
be unfounded when examining outcomes on a national
level. lA separate additional analysis of female patients found
hat asymptomatic women were more likely to undergo
EA vs CAS, whereas symptomatic women were more
ikely to have undergone CAS. The reasons behind this
election bias are unclear. Overall, as would be expected,
ymptomatic women undergoing intervention had a signif-
cantly increased rate of postoperative stroke than asymp-
omatic women. In addition, female patients undergoing
AS had a significantly higher rate of postoperative stroke
han those undergoing CEA (2.7% vs 1.1%, P  .001).
urthermore, in analysis of asymptomatic women alone,
hose undergoing CAS had a significantly higher rate of
ostoperative stroke than those undergoing CEA (2.1% vs
.9%, P  .001). Among symptomatic women, the rate of
ostoperative stroke was also notably higher with CAS than
ith CEA (6.2% vs 3.4%), although this did not reach
tatistical significance (P  .1). In addition, the in-hospital
ortality rate for symptomatic female patients undergoing
AS was concerning (3.7%). On the basis of these results,
e believe that CEA may be the preferred intervention for
emale patients with appropriate indications for carotid
ntervention, particularly when asymptomatic.
The possible reasons for the increased rates of peripro-
edural stroke among female patients undergoing CAS vs
EA, unfortunately, cannot be elucidated from this study
ecause extensive risk stratification was not performed.
otential etiologic factors could include inherent differ-
nces in anatomy, carotid artery diameter, and the extent of
nderlying aortic arch and cerebrovascular disease. Other
issimilarities in the female patient cohorts undergoing the
wo procedures could include a different pattern of medical
omorbidities, medication use, and hormonal variations. It
s certainly possible that the women who underwent CAS
ere at high risk for CEA from a medical or surgical point
f view. However, despite these possible biases in patient
election, the current data provide information on the
ctual results of the procedures chosen by the patients’
hysicians.
A prior report by McPhee et al,33 also using the NIS,
ound that during the years 2003 and 2004, the in-hospital
troke rate after CAS for asymptomatic patients was two-
old higher than after CEA. The respective in-hospital
troke and mortality rates for symptomatic patients were
ourfold and sevenfold higher.33 These results support our
ndings in the more detailed analysis of female patients. An
dditional recent report analyzing 47,752 CAS or CEA
ospitalizations also found that for symptomatic patients
ndergoing CAS, the rates of mortality and combined
troke/mortality were significantly higher for CAS than for
EA.34 In contrast to the current report, however, these
uthors found no differences across endovascular and open
rocedures in asymptomatic patients.
An unexpected finding from the current analysis was
hat there appears to be a sex-based selection bias with
egard to the type of carotid intervention performed. Men
ere more likely to undergo CAS than women (6.1% vs
.4%, P  .001); likewise, asymptomatic men were more
ikely to undergo CAS than asymptomatic women (5.8% vs
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Volume 53, Number 6 Rockman et al 14634.8%, P .001). In contrast to these findings, symptomatic
male patients were less likely to undergo CAS than symp-
tomatic female patients (11.9% vs 13.5%). The reasons
behind these biases in the selection of procedure based on
sex cannot be elucidated here. Symptomatic female patients
as a whole may possibly have an increased prevalence of
medical comorbidities, making them a high-risk cohort for
CEA. A further unexpected finding was that it appears that
nationwide, more than 90% of carotid artery interventions
are being performed for asymptomatic disease. We are not
sure whether this represents reality or whether this is related
to a problem with the way the preoperative diagnosis of
patients is coded in this administrative database. Despite
the level I evidence that supports the role of CEA in stroke
prevention for asymptomatic severe carotid artery stenosis,
there has been renewed concern recently regarding proper
selection for asymptomatic patients.35 Clearly, we need
better ways to identify which asymptomatic patients are
truly at increased risk for stroke in addition to the degree of
stenosis alone.
Finally, with improvements in pharmacologic treat-
ments, including antiplatelet therapies and cholesterol-
lowering medications, it is certainly conceivable that prior
studies do not represent a contemporary “best medical
therapy” scenario. Although we do believe that there is a
role for CEA in stroke prevention for severe carotid artery
disease, we do join other experts in recommending caution
in choosing appropriate asymptomatic patients for prophy-
lactic carotid intervention.
The present analysis has some limitations. We did not
perform extensive risk stratification analysis to ensure that
the male and female patient populations, and the CEA and
CAS cohorts, were equivalent from a demographic and
medical comorbidity perspective. However, the most im-
portant risk factor for periprocedural stroke is the preoper-
ative symptomatic status of the patient, and this was ana-
lyzed in detail.
The analysis is retrospective and uses a national adminis-
trative database, which may have inherent flaws. The use of a
database or registry risks the presence of erroneous,miscoded,
or missing data points. Different techniques, practices, and
interventions are not coded or controlled for; for example, the
percentage of CEAs performed with patch angioplasty vs
primary repair cannot be reported here. Patient profiles are
likely not uniform, with a variable prevalence of risk factors.
However, one would expect such discrepancies to be distrib-
uted across the interventions and patient cohorts impartially
and therefore should minimize their effect on the reported
outcomes. In contrast, the advantages of such an analysis are
the large numbers of cases available for analysis and the pre-
sentation of a real-world view rather than single-institution
reports, or even carefully controlled clinical trials that may
represent a best-world scenario that might be difficult to
achieve on a national level.
CONCLUSIONS
The NIS database offers a view of national outcomes
with carotid artery interventions. In addition to the avail-bility of obviously large numbers of cases for analysis, it
ffers important insight into what is actually happening at
ocietal level, alleviating individual institutional biases.
Analysis of this national database reveals that the con-
ern regarding an increased perioperative stroke rate after
EA among asymptomatic women appears to be un-
ounded. Overall, regardless of symptomatic status or the
rocedure performed, female patients undergoing carotid
ntervention had a nearly equivalent outcome compared
ith their male counterparts. Although the overall periop-
rative stroke rate among symptomatic women undergoing
arotid intervention was higher than that of symptomatic
en, this was still well within the acceptable range for
ymptomatic patients undergoing cerebrovascular inter-
ention. Nationally, women underwent CAS significantly
ess frequently than did men. Outcome among women for
erioperative stroke favored CEA over CAS, particularly in
symptomatic patients. These data appear to show that
EAmay be the preferred treatment in female patients who
arrant intervention for cerebrovascular disease, unless
ompelling reasons exist to perform CAS.
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This article describes perioperative stroke and death rates for
carotid endarterectomy and coronary angioplasty and stenting
derived from 20% of United States inpatient episodes during 2004
and 2005. Some important factors prevent comparisons with lon-
ger-term clinical trials or cohort studies. The stroke and death rates
quoted here are likely to underestimate outcomes; around one-
third of 30-day events occurred after discharge.
Somewhat confusingly, there is no definition of the events: Is
fatal stroke recorded as death, or stroke (or twice)? Recording of
fatal stroke as an inpatient could clarify this. The authors express
surprise that for 95% of procedures, patients were asymptomatic,
“an unexpected finding,” yet somewhat disingenuously, they also
feel that one of the study strengths is that it represents the “real-
world” view.
Women comprised 42% of the patients in the 2-year study
period, contrasting with previous clinical trials and audits whereentioned in this study, and this is particularly unfortunate be-
ause there is level 1 evidence from the large Asymptomatic Ca-
otid Surgery Trial clearly showing that benefit from surgery was
nly clearly demonstrated for younger (75 years) asymptomatic
atients.1
Although the authors mention that preoperative medications
ay influence postoperative outcome, this area has not been
xplored.2 This is of interest because, during the period of this
tudy, statin usage was rapidly increasing, having been shown to be
eneficial in the Heart Protection Study and more recently rein-
orced by the Cholesterol Trialists Collaboration report.3 There is
ow no possibility to conduct randomized controlled trials of
tatin usage, and only studies such as this covering the period when
hey were gaining widespread use can shed light on the possibility
hat they may protect patients from perioperative stroke.
In summary, the authors are to be congratulated for their
ensible analysis of current United States practice and dispelling
